Victor P. Rochetti
Rio De Janeiro, RJ, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Auranofin and iodoquinol as promising repurposing drugs against filamentous fungi: antifungal activity and cellular alterations.
Journal: Microbiology spectrum
Published: February 27, 2026
Miltefosine: A Repurposing Drug against Mucorales Pathogens.
Journal: Journal of fungi (Basel, Switzerland)
Published: October 09, 2023
Promising Antifungal Molecules against Mucormycosis Agents Identified from Pandemic Response Box®: In Vitro and In Silico Analyses.
Journal: Journal of fungi (Basel, Switzerland)
Published: December 23, 2022
Identification of Promising Antifungal Drugs against Scedosporium and Lomentospora Species after Screening of Pathogen Box Library.
Journal: Journal of fungi (Basel, Switzerland)
Published: August 28, 2021
Miltefosine Against Scedosporium and Lomentospora Species: Antifungal Activity and Its Effects on Fungal Cells.
Journal: Frontiers in cellular and infection microbiology
Published: April 21, 2021
Glucosylceramide Plays a Role in Fungal Germination, Lipid Raft Organization and Biofilm Adhesion of the Pathogenic Fungus Scedosporium aurantiacum.
Journal: Journal of fungi (Basel, Switzerland)
Published: October 29, 2020
Peptidorhamnomannans From Scedosporium and Lomentospora Species Display Microbicidal Activity Against Bacteria Commonly Present in Cystic Fibrosis Patients.
Journal: Frontiers in cellular and infection microbiology
Published: August 25, 2020
Scedosporium Cell Wall: From Carbohydrate-Containing Structures to Host-Pathogen Interactions.
Journal: Mycopathologia
Published: April 16, 2020
Sphingolipid biosynthetic pathway is crucial for growth, biofilm formation and membrane integrity of Scedosporium boydii.
Journal: Future medicinal chemistry
Published: November 13, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026